Clinical trial
A Non-interventional Protocol to Collect Prospective and Retrospective Data in Patients Receiving Everolimus to Prevent Acute Rejection Following Cardiac Transplantation
NCT00134940 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Protocol to Collect Prospective and Retrospective Data in Patients Receiving Everolimus to Prevent Acute Rejection Following Cardiac Transplantation
- Lead sponsor
- Novartis
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- November 30, 2006
- Enrollment
- 100 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease